Management of Vomiting in a Patient with Meningitis on Treatment
Administer ondansetron intravenously as the first-line antiemetic agent, ensure adequate IV fluid resuscitation to prevent dehydration, and continue appropriate antimicrobial therapy without interruption. 1, 2
Immediate Antiemetic Therapy
Ondansetron is the preferred antiemetic agent for managing vomiting in meningitis patients due to its superior efficacy and safety profile compared to other antiemetics. 2
- Administer ondansetron 4-8 mg IV over 2-5 minutes, which can be repeated every 4-6 hours as needed for persistent vomiting 1
- Ondansetron is not associated with sedation or extrapyramidal side effects (akathisia), making it safer than dopamine antagonists in acutely ill patients 2
- Do not use the oral route when active vomiting is present, as absorption will be inadequate 1
Alternative Antiemetic Options
If ondansetron is unavailable or ineffective:
- Metoclopramide 10 mg IV every 6-8 hours can be used, but monitor closely for akathisia which can develop within 48 hours of administration 1, 2
- Prochlorperazine 5-10 mg IV every 6-8 hours is another option, though it also carries risk of extrapyramidal side effects 1, 2
- Decreasing the infusion rate of these dopamine antagonists can reduce the incidence of akathisia, and diphenhydramine IV can treat this adverse effect if it occurs 2
Fluid Resuscitation and Electrolyte Management
Vomiting in meningitis patients creates a dual threat: both the underlying infection and volume depletion can worsen outcomes.
- Administer 0.9% normal saline 1 liter IV over the first hour to rapidly restore intravascular volume 1
- Continue isotonic saline infusion at a slower maintenance rate for 24-48 hours with frequent monitoring 1
- Draw serum electrolytes (Na, K), creatinine, BUN, and glucose before initiating therapy to identify baseline abnormalities 1
- Check and correct electrolyte abnormalities, particularly hypokalemia and metabolic alkalosis that commonly develop with protracted vomiting 1
- Maintain strict monitoring of fluid intake and output to assess response and prevent fluid overload 1
Continue Antimicrobial Therapy Without Interruption
The presence of vomiting should never delay or interrupt appropriate antibiotic therapy for meningitis. 3
- All antimicrobial agents for meningitis are administered intravenously, so vomiting does not affect drug delivery 3
- For pneumococcal meningitis: continue ceftriaxone 2 g IV every 12 hours or cefotaxime 2 g IV every 6 hours 3
- For meningococcal meningitis: continue ceftriaxone 2 g IV every 12 hours or cefotaxime 2 g IV every 6 hours 3
- Treatment duration should not be shortened due to vomiting complications 3
Additional Supportive Measures
- Consider gastric acid suppression with proton pump inhibitors or H2 blockers if gastric irritation is contributing to persistent nausea 1
- Administer antiemetics around-the-clock rather than PRN dosing for better symptom control 3
- Multiple concurrent antiemetic agents from different drug classes may be necessary in refractory cases 3
Critical Pitfalls to Avoid
- Do not delay fluid resuscitation while waiting for laboratory results—clinical presentation of vomiting mandates immediate IV fluid therapy 1
- Never discontinue or delay antibiotics due to vomiting, as bacterial meningitis is a medical emergency where treatment delays increase mortality 3, 4, 5
- Do not use promethazine as first-line therapy due to excessive sedation and potential for vascular damage with IV administration 2
- Avoid droperidol except in refractory cases due to FDA black box warning regarding QT prolongation 2
Monitoring and Reassessment
- Reassess antiemetic efficacy after 24 hours and adjust therapy as needed 1
- Monitor for signs of dehydration including decreased urine output, tachycardia, and hypotension 1
- If vomiting persists despite optimal antiemetic therapy, investigate alternative causes including increased intracranial pressure, cerebral edema, or other complications of meningitis 5
- Document Glasgow Coma Scale serially to detect neurological deterioration 3